Refine by
Heart Damage Equipment & Supplies
16 equipment items found
Manufactured by:Optibio Co., Ltd. based inCheongju-si, SOUTH KOREA
Creatine Kinase-MB (CK-MB) is a form of enzyme found primarily in heart muscle cells. CK-MB is one of three forms of the enzyme creatine kinase and is released from the muscle cells and is detectable in the blood when there is muscle damage in the heart. When there is an increased presence of CK-MB in the blood, the CK-MB test can be used to ...
Manufactured by:U.S. Stem Cell, Inc. (USRM) based inSunrise, FLORIDA (USA)
Stem Cell’s lead product candidate is MyoCell®, a muscle stem cell therapy that is intended to improve cardiac function months or even years after a patient has suffered severe heart damage due to a heart attack. The procedure involves a physician removing a small amount of muscle from the patient’s thigh. From this muscle ...
Manufactured by:advanceCOR GmbH based inPlanegg, GERMANY
This is the name of our therapeutic agent for the prevention of stroke and heart attack. Its principle effectiveness has already been proven in patients. It is a soluble protein which, when blood vessels are damaged, covers the damaged areas. Revacept is designed to protect the vessel walls so that vascular occlusion does not occur. ...
Manufactured by:Khloris Biosciences, Inc. based inMountain View, CALIFORNIA (USA)
Khloris' iPSCs are optimized to generate high-functioning cardiomyocytes, enabling development of an allogeneic source of donor cells for patients with damaged heart ...
Manufactured by:Vitrosens Biotechnology A.S. based inÜmraniye, TURKEY
Test kit is specifically designed for the qualitative determination of Creatine kinase-MB (CK-MB) protein in human serum, plasma, and whole blood ...
Manufactured by:Boditech Med Inc. based inGangwon-do, SOUTH KOREA
Tn-I, CK-MB, and Myoglobin are secreted in blood after the heart gets injured by cardiac stress for the lack of oxygen. The levels of these biomarkers can reveal the degree of a heart attack or damage. It would test for the level of those biomarkers in the blood to assist clinicians to assess the cardiac health ...
by:Accelerated Biosciences Corp. based inCarlsbad, CALIFORNIA (USA)
Stem cells possess two defining characteristics that give potential to address unmet medical needs in healthcare: 1) the ability to self-replicate throughout the life of an organism and 2) the ability to differentiate to many different cell types in the human ...
by:GW Pharmaceuticals plc based inCambridge, UNITED KINGDOM
NHIE is acute or sub-acute brain injury due to asphyxia caused during birth resulting from deprivation of oxygen during birth (hypoxia) as a result of a sentinel event such as ruptured placenta, parental shock and even increased heart rate. Hypoxic damage can occur to most of the infant’s organs, but brain damage is the most serious and ...
Manufactured by:U.S. Stem Cell, Inc. (USRM) based inSunrise, FLORIDA (USA)
MyoCell SDF-1 has received approval from the FDA to begin human clinical trials and is intended to be an improvement to MyoCell. The myoblast cells to be injected are gene-modified prior to injection by an adenovirus vector so that they will release extra quantities of stromal derived factor – 1 or SDF-1 protein. Following injury which results in inadequate blood flow to the heart, such as ...
Manufactured by:Itamar Medical Ltd. based inAtlanta, GEORGIA
What if you could identify high risk patients at the earliest stage of their cardiovascular disease - would you treat them differently? The EndoPAT – the only FDA-cleared test for the non-invasive assessment of Endothelial Dysfunction (arterial health); clinically proven by leading cardiologists through prestigious peer-reviewed studies as a valuable tool in cardiovascular risk ...
Manufactured by:Genesis Medical Plastics based inCypress, TEXAS (USA)
The cardiovascular system spans the entire body, supported by the constant pumping of the heart. In effect, the cardiovascular system is the body’s supply chain, and if it fails, the rest of the body does as well. Medical science and engineering have placed much focus on protecting and repairing the heart, even going as far as ‘backing it up’ with an implantable defibrillator. ...
by:Alucent Biomedical Inc. based inSalt Lake City,, UTAH (USA)
PAD is a common circulatory problem in which narrowed arteries reduce blood flow to the extremities – generally affecting one or both legs. It is caused when the inner lining of arteries located outside of the heart get damaged by factors such as smoking, obesity, high blood pressure, elevated cholesterol, elevated triglyceride levels, and/or diabetes. Once ...
Manufactured by:CellProthera based inMulhouse, FRANCE
The unique therapeutic approach proposed by CellProthera is protected by various patents. It requires a simple blood sampling best performed within 2 weeks following a severe AMI. The sampling occurs after a treatment period using GCSF in order to mobilize the patient’s own stem cells into the blood flow. The patient’s blood sample is then forwarded to a local certified Cell Therapy ...
Manufactured by:MedChemExpress LLC (MCE) based inMonmouth Junction, NEW JERSEY (USA)
Morin is an orally active plant-derived flavonoid. Morin inhibits ROS generation. Morin induces Apoptosis. Morin inhibits PTP1B (IC50 of 15 μM) and activates the insulin receptor. Morin has a detoxifying effect. Morin can be used in diabetes, leukemia, colon cancer, cervical cancer, Parkinson's disease and hypertension ...
Manufactured by:BlueRock Therapeutics based inCambridge, MASSACHUSETTS (USA)
With our cell+gene platform, BlueRock is aiming to redefine the very way we treat disease, moving from addressing mere symptoms to restoring health lost to cell damage or degeneration. Instead of prescribing a pill to treat tremors in patients with Parkinson’s, we might restore the chemical messengers that were destroyed, addressing tremors at the source. Those who have ...
Manufactured by:Therawis based inMunich, GERMANY
The acute SARS-CoV-2 infection is diagnosed routinely through PCR-based detection of viral RNA from nasopharyngeal swabs. Additionally, direct antigen detection of viral proteins is now available. The specific detection by PCR has a high sensitivity and specificity but delivers a false-negative rate of up to 38 % at the time of symptoms (Kucirka et al. 2020). The sensitivity and specificity of ...